1. Where Does a Delisting Case Actually Go?
A delisting dispute does not ordinarily begin in federal district court. Review starts within the exchange and may later move to the SEC and a U.S. Court of Appeals.
Start with the Exchange Review Path
A deficiency notice and a staff delisting determination are different events. First identify which notice arrived and which rule starts the clock.
- Nasdaq: Rule 5815 generally gives seven calendar days to request Hearings Panel review.
- NYSE: Section 804.00 generally gives ten business days to request review of a staff delisting determination.
- Trading: A review request does not always keep the security trading.
For the broader listing framework, see Capital Markets & Securities.
Sec and Court Review Come Later
Nasdaq also provides further internal review after a Panel Decision. An issuer seeking SEC review should identify available exchange remedies before moving to that stage.
| Stage | Forum | General Filing Window |
|---|---|---|
| Nasdaq staff determination | Hearings Panel | Generally 7 calendar days |
| NYSE staff determination | Committee for Review | Generally 10 business days |
| SEC review | SEC | Generally 30 days under Rule 420 |
| Final SEC order | U.S. Court of Appeals | 60 days after entry |
2. What Should the Issuer Do before the First Deadline?
A lawyer cannot create a cure period that the exchange rules do not provide. The immediate job is to identify the notice, calendar the deadline, and separate compliance work from appeal work.
Separate Cure Periods from Appeal Deadlines
Some deficiencies allow time to regain compliance, while others move quickly toward suspension or delisting. The determination letter matters more than a generic timeline.
- Identify the exact continued-listing standard at issue.
- Confirm whether a cure period, compliance plan, or immediate review path applies.
- Calendar hearing, disclosure, board, and stay dates separately.
Build the Record Early
The record created at the exchange stage can matter later. Organize existing documents before briefing positions become fixed.
- Collect the exchange notice, earlier deficiency letters, and issuer responses.
- Preserve financial data, board materials, and compliance evidence.
- Track which factual and legal issues were raised at each stage.
Related federal requirements are discussed in Securities Regulations.
3. Who Should Lead the Matter and What Should the Issuer Budget?
Two law firms are not automatically required. Staffing and budget should follow the current forum, the record, and the work needed if the matter escalates. One team may handle several stages, but the issuer should know in advance when accounting, SEC procedure, or appellate work will require additional specialists.
Match the Lead Attorney to the Current Stage
The work changes as the case moves forward. Exchange review centers on listing standards, while later review becomes more record-driven.
- Exchange phase: Address the cited standard and build the compliance record.
- SEC phase: Frame review issues and any separate stay request.
- Appellate phase: Present preserved issues within the federal review framework.
Budget by Workstream, Not a Headline Rate
There is no reliable universal price for a contested delisting matter. A phased budget is more useful than an unsupported hourly-rate estimate. Before comparing proposals, ask whether the quoted scope includes the hearing, stay work, outside experts, disclosure support, and any later federal review.
| Phase | Main Cost Drivers |
|---|---|
| Cure or response | Rule analysis, financial review, and compliance planning |
| Exchange review | Record preparation, briefing, hearing, and accounting support |
| Federal review | SEC application, stay work, record analysis, and appellate briefing |
For broader appellate procedure, see Federal Appeals.
4. What Happens to Trading and Disclosure during Review?
Appeal rights and trading status do not always move together. Disclosure has its own clock, so trading, review, and reporting should be tracked separately.
Do Not Assume an Appeal Keeps Trading Open
A timely Nasdaq hearing request ordinarily stays suspension and delisting, but Rule 5815 contains exceptions. Later review can also continue while trading remains suspended. Management should therefore treat the legal right to seek review and the practical status of trading as two separate questions.
- Read the determination letter before describing the expected trading status.
- Check whether a stay applies or separate relief must be requested.
- Avoid promising that an appeal will preserve exchange trading.
Disclosure Runs on a Separate Deadline
For domestic issuers, a qualifying listing notice can trigger Form 8-K Item 3.01. When Item 3.01 applies, the filing is generally due within four business days.
- Identify the disclosure trigger when the exchange notice arrives.
- Match the filing to the cited rule and current procedural status.
- Use the separate reporting framework for foreign private issuers when relevant.
For broader disclosure issues, see Disclosure Statements.
5. Frequently Asked Questions
Can an issuer skip exchange review and go straight to federal district court?
That is not the ordinary statutory review path for a delisting determination. Exchange and SEC procedures may come first, with a final SEC order generally reviewed in a U.S. Court of Appeals.
Does filing a Nasdaq hearing request always keep the stock trading?
No. A timely request ordinarily has a stay effect under Rule 5815, but exceptions apply. Check the current rule and determination letter immediately.
Can one firm handle the exchange, SEC, and appellate stages?
Yes, if the firm can cover the required procedures and forum. A second firm is not automatically necessary, although specialized support may become useful later.
Can a lawyer prevent the stock price from falling after a delisting notice?
No. Attorneys can address procedure, disclosure, stays, and review rights, but they cannot control market pricing or guarantee continued exchange trading.
6. Ask Sjkp to Map the Delisting Review Path
SJKP's attorneys can review the exchange notice, listing standard, procedural calendar, disclosure record, and likely next forum. The review can identify the current stage, available options, and staffing needs if the matter moves into SEC or appellate review.
24 Aug, 2026
